The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
HIV treatment that can be injected every one or two months has been approved for use in some countries. What does it mean for people with HIV across the world?
More people with HIV benefited from effective treatment after it was provided in vans parked in convenient places like community centres and sports fields
The HARTS trial suggests age should not be used to judge readiness to move, as things such as being able to understand treatment and ask questions are more important
Ugandan study suggests peer educators, visiting adult clinics, counselling and education can all make the transition process go smoothly.
Review initially finds dolutegravir has no links to birth defects then revises its findings to report a ‘slightly higher’ – but minimal – incidence after two cases emerge
National data from five Southern African countries suggests nearly 89% of adults on HIV treatment are virally suppressed – but gaps remain.
Malawians in some rural areas face travel times to HIV clinics that are almost double others’ journeys.
Rates of viral suppression among men significantly increase – and approach that of women – when services are provided in the community instead of in-clinic.
Long-acting, injectable cabotegravir is as effective as daily PrEP pills at preventing HIV among cisgender men and transgender women who have sex with men.
People on integrase inhibitors found to gain more weight on average than those on other treatment regimens